Table 2 Virological response in the studied patients
Viral load | Studied patients (N = 240) |
|---|---|
Viral load on 4th week | |
< 15 IU/L | 156 (65.0%) |
> 15 IU/L | 84 (35.0%) |
Viral load on 8th week | |
< 15 IU/L | 212 (88.3%) |
> 15 IU/L | 28 (11.7%) |
Viral load on 12th week | |
< 15 IU/L | 240 (100.0%) |
> 15 IU/L | 0 (0.0%) |
Viral load on 24th week | |
< 15 IU/L | 240 (100.0%) |
> 15 IU/L | 0 (0.0%) |
Viral load on 12th week post-treatment | |
< 15 IU/L | 231 (96.3%) |
> 15 IU/L | 9 (3.7%) |
SVR | |
Yes | 231 (96.3%) |
No | 9 (3.7%) |